Company Shifts Focus to FDA-Approved Weight Loss Drugs
Hims & Hers Health reported a first-quarter loss following a strategic pivot toward weight-loss medications. The company is prioritizing FDA-approved treatments and compounded GLP-1 receptor agonists to address obesity, incurring ... Read More